Mirum
Mirum Pharmaceuticals
Quick answer
Mirum is a pharma company (MIRM) headquartered in FOSTER CITY, CA, USA with 24 tracked pipeline programs.
Pipeline (24)
Blinded CDCA 250 mg TID
CTX
1 trials projectBrelovitug (BJT-778)
Chronic Hepatitis D
1 trials projectBrelovitug 300 mg
Chronic Hepatitis D Infection
3 trials projectCholic Acid
Bile Acid Synthesis Defect
1 trials projectCholic Acids
Infantile Refsum's Disease
1 trials projectCholic acid
Inborn Errors of Bile Acid Synthesis
1 trials projectMaralixibat
Progressive Familial Intrahepatic Cholestasis (PFIC)
3 trials projectMaralixibat
Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
1 trials projectLUM001
Primary Biliary Cirrhosis
1 trials projectLUM001
Alagille Syndrome
2 trials projectLUM001
PBC
1 trials projectLUM001
Primary Sclerosing Cholangitis (PSC)
1 trials projectLUM001 (Maralixibat)
Progressive Familial Intrahepatic Cholestasis (PFIC)
1 trials projectLUM001 (Maralixibat)
Alagille Syndrome
3 trials projectLow dose of MRM-3379
Fragile X Syndrome
1 trials projectMaralixibat
Intrahepatic Cholestasis of Pregnancy
1 trials projectMaralixibat
Progressive Familial Intrahepatic Cholestasis
1 trials projectMaralixibat
Biliary Atresia
1 trials projectMaralixibat
Cholestatic Liver Disease
1 trials projectSHP626
Non-Alcoholic Steatohepatitis
3 trials projectVolixibat
Intrahepatic Cholestasis of Pregnancy
1 trials projectVolixibat
Primary Sclerosing Cholangitis
1 trials projectVolixibat
Primary Biliary Cholangitis
1 trials projectPlacebo
Healthy Volunteers
1 trials